Pricing

ATALAYA CAPITAL MANAGEMENT LP

0 followers ·
NEW YORK NY Investment Advisor Hedge Fund
13F Summary
Atalaya Capital Management is based out of New York. Atalaya Capital Management is a hedge fund with 62 clients and discretionary assets under management (AUM) of $9,111,483,439 (Form ADV from 2024-03-29). Their last reported 13F filing for Q1 2024 included $85,089,671 in managed 13F securities and a top 10 holdings concentration of 90.01%. Atalaya Capital Management's largest holding is Aeon Biopharma Inc with shares held of 3,675,000. Whalewisdom has at least 14 13F filings, 108 13G filings, and 13 Form 4 filings

2024-03-31

Top Buys (13F)

Name % Change
TQQQ ProShares UltraPro Q 15.92%
CNDT Conduent Inc 2.04%
SOC-WT SABLE OFFSHORE CORP 0.3%
OPTXW Syntec Optics Holdin 0.14%
CEROW CERo Therapeutics Ho 0.04%

2024-03-31

Top Sells (13F)

2024-03-31

13F Holdings Summary

Name $ Change
AEON Aeon Biopharma Inc 42.59%
TQQQ ProShares UltraPro Q 15.92%
LNZA LanzaTech Global Inc 10.66%
CNDT Conduent Inc 6.25%
HLLY Holley Inc 4.34%

2024-03-31

13F Activity

Market Value $85.1m, Prior: $69.3m
Inflows (Outflows) as % of Total MV +13.7355%
New Purchases 4 stocks
Added To 5 stocks
Sold out of 10 stocks
Reduced holdings in 2 stocks
Top 10 Holdings % 90.01%
Turnover %[1] 11.2%
Turnover Alt %[2] 7.66%
Time Held Top 20 1.95 quarters
Time Held Top 10 1.5 quarters
Time Held All 7.22 quarters

[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.

[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.

2024-03-31

13F Sector Allocation Over Time

2024-03-31

Analysis

Top 20 equal-weighted holdings. Performance numbers calculated through 2024-03-31

Portfolio Performance